<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "http://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="methods-article" dtd-version="1.2" xml:lang="en">
    <front>
        <journal-meta>
            <journal-id journal-id-type="pmc">Gates Open Res</journal-id>
            <journal-title-group>
                <journal-title>Gates Open Research</journal-title>
            </journal-title-group>
            <issn pub-type="epub">2572-4754</issn>
            <publisher>
                <publisher-name>F1000 Research Limited</publisher-name>
                <publisher-loc>London, UK</publisher-loc>
            </publisher>
        </journal-meta>
        <article-meta>
            <article-id pub-id-type="doi">10.12688/gatesopenres.15220.1</article-id>
            <article-categories>
                <subj-group subj-group-type="heading">
                    <subject>Method Article</subject>
                </subj-group>
                <subj-group>
                    <subject>Articles</subject>
                </subj-group>
            </article-categories>
            <title-group>
                <article-title>Flip the Script: Rebranding ART and enhancing the U=U message in Malawi and Zimbabwe</article-title>
                <fn-group content-type="pub-status">
                    <fn>
                        <p>[version 1; peer review: 1 not approved]</p>
                    </fn>
                </fn-group>
            </title-group>
            <contrib-group>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Ngaragari</surname>
                        <given-names>Tom</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Conceptualization</role>
                    <role content-type="http://credit.niso.org/">Data Curation</role>
                    <role content-type="http://credit.niso.org/">Project Administration</role>
                    <role content-type="http://credit.niso.org/">Supervision</role>
                    <role content-type="http://credit.niso.org/">Validation</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Original Draft Preparation</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <xref ref-type="aff" rid="a1">1</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Hasen</surname>
                        <given-names>Nina</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Conceptualization</role>
                    <role content-type="http://credit.niso.org/">Data Curation</role>
                    <role content-type="http://credit.niso.org/">Funding Acquisition</role>
                    <role content-type="http://credit.niso.org/">Project Administration</role>
                    <role content-type="http://credit.niso.org/">Supervision</role>
                    <role content-type="http://credit.niso.org/">Validation</role>
                    <role content-type="http://credit.niso.org/">Visualization</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <xref ref-type="aff" rid="a2">2</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Hermann</surname>
                        <given-names>Montague</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Data Curation</role>
                    <role content-type="http://credit.niso.org/">Validation</role>
                    <role content-type="http://credit.niso.org/">Visualization</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Original Draft Preparation</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <xref ref-type="aff" rid="a3">3</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Kunaka</surname>
                        <given-names>Nigel</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Conceptualization</role>
                    <role content-type="http://credit.niso.org/">Data Curation</role>
                    <role content-type="http://credit.niso.org/">Investigation</role>
                    <role content-type="http://credit.niso.org/">Supervision</role>
                    <role content-type="http://credit.niso.org/">Validation</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <xref ref-type="aff" rid="a4">4</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Mkandawire</surname>
                        <given-names>Philip</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Conceptualization</role>
                    <role content-type="http://credit.niso.org/">Data Curation</role>
                    <role content-type="http://credit.niso.org/">Formal Analysis</role>
                    <role content-type="http://credit.niso.org/">Investigation</role>
                    <role content-type="http://credit.niso.org/">Methodology</role>
                    <role content-type="http://credit.niso.org/">Supervision</role>
                    <role content-type="http://credit.niso.org/">Validation</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <xref ref-type="aff" rid="a5">5</xref>
                </contrib>
                <contrib contrib-type="author" corresp="yes">
                    <name>
                        <surname>Nhamo-Murire</surname>
                        <given-names>Mercy</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Data Curation</role>
                    <role content-type="http://credit.niso.org/">Formal Analysis</role>
                    <role content-type="http://credit.niso.org/">Investigation</role>
                    <role content-type="http://credit.niso.org/">Methodology</role>
                    <role content-type="http://credit.niso.org/">Validation</role>
                    <role content-type="http://credit.niso.org/">Visualization</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Original Draft Preparation</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <uri content-type="orcid">https://orcid.org/0000-0002-6244-7321</uri>
                    <xref ref-type="corresp" rid="c1">a</xref>
                    <xref ref-type="aff" rid="a6">6</xref>
                </contrib>
                <contrib contrib-type="author" corresp="yes">
                    <name>
                        <surname>Ferrand</surname>
                        <given-names>Andrea</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Conceptualization</role>
                    <role content-type="http://credit.niso.org/">Funding Acquisition</role>
                    <role content-type="http://credit.niso.org/">Validation</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <xref ref-type="corresp" rid="c2">b</xref>
                    <xref ref-type="aff" rid="a2">2</xref>
                </contrib>
                <aff id="a1">
                    <label>1</label>Population Services International, Nairobi, Kenya</aff>
                <aff id="a2">
                    <label>2</label>Population Services International, Washington, District of Columbia, USA</aff>
                <aff id="a3">
                    <label>3</label>Consultant, Washington DC, District of Columbia, USA</aff>
                <aff id="a4">
                    <label>4</label>Population Solutions for Health, Harare, Zimbabwe</aff>
                <aff id="a5">
                    <label>5</label>Family Health Services, Lilongwe, Malawi</aff>
                <aff id="a6">
                    <label>6</label>Population Services International, Johannesburg, Gauteng, 2092, South Africa</aff>
            </contrib-group>
            <author-notes>
                <corresp id="c1">
                    <label>a</label>
                    <email xlink:href="mailto:mercy@psi-sa.org">mercy@psi-sa.org</email>
                </corresp>
                <corresp id="c2">
                    <label>b</label>
                    <email xlink:href="mailto:aferrand@psi.org">aferrand@psi.org</email>
                </corresp>
                <fn fn-type="conflict">
                    <p>No competing interests were disclosed.</p>
                </fn>
            </author-notes>
            <pub-date pub-type="epub">
                <day>26</day>
                <month>4</month>
                <year>2024</year>
            </pub-date>
            <pub-date pub-type="collection">
                <year>2024</year>
            </pub-date>
            <volume>8</volume>
            <elocation-id>35</elocation-id>
            <history>
                <date date-type="accepted">
                    <day>11</day>
                    <month>4</month>
                    <year>2024</year>
                </date>
            </history>
            <permissions>
                <copyright-statement>Copyright: &#x00a9; 2024 Ngaragari T et al.</copyright-statement>
                <copyright-year>2024</copyright-year>
                <license xlink:href="https://creativecommons.org/licenses/by/4.0/">
                    <license-p>This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
            </permissions>
            <self-uri content-type="pdf" xlink:href="https://gatesopenresearch.org/articles/8-35/pdf"/>
            <abstract>
                <sec>
                    <title>Background</title>
                    <p>Since 2009, global efforts have made significant strides in identifying and treating People Living with HIV (PLHIV), with the number on Antiretroviral Therapy (ART) surpassing 25 million by 2020. However, challenges persist as a substantial number of individuals enrolled in ART, particularly in countries like Zimbabwe and Malawi, are lost to follow-up, impeding the success of HIV response initiatives. Stigma and limited awareness continue to pose barriers to effective HIV management.</p>
                </sec>
                <sec>
                    <title>Methods</title>
                    <p>The methodology centres on identifying compelling messengers to bridge the gap between medical information and lived experiences in sub-Saharan Africa. Grounded in human-centered and co-design approaches, the initiative engages host country governments, stakeholders, influencers, and the target audience to create a globally resonant brand with country-specific adaptations.</p>
                </sec>
                <sec>
                    <title>Results</title>
                    <p>The "Undetectable = Untransmittable" (U=U) movement, founded in 2016, emphasizes that PLHIV with undetectable viral loads cannot transmit the virus, playing a crucial role in dismantling stigma and enhancing HIV prevention efforts. To address the low awareness of U=U in Malawi and Zimbabwe, the collaborative "Flip the Script" project was launched, involving public and various private sectors. This initiative aims to reshape perceptions around ART, presenting it as a key to a normalized, healthy life rather than a symbol of infection. "Flip the Script" seeks to boost ART initiation and re-initiation, promote effective ART use, and encourage viral load testing and result sharing among PLHIV. It also strives for consistent counseling on the prevention benefits of ART by health providers.</p>
                </sec>
                <sec>
                    <title>Conclusions</title>
                    <p>Ultimately, the initiative aims to increase the percentage of PLHIV achieving and sustaining viral suppression, leading to a reduction in HIV incidence. Its success hinges on effectively communicating the U=U message, challenging stigma, and empowering both PLHIV and health providers in the targeted regions.</p>
                </sec>
            </abstract>
            <kwd-group kwd-group-type="author">
                <kwd>U=U</kwd>
                <kwd>viral suppression</kwd>
                <kwd>stigma</kwd>
                <kwd>Malawi</kwd>
                <kwd>Zimbabwe</kwd>
            </kwd-group>
            <funding-group>
                <award-group id="fund-1" xlink:href="http://dx.doi.org/10.13039/100000865">
                    <funding-source>Gates Foundation</funding-source>
                    <award-id>INV-019356</award-id>
                </award-group>
                <funding-statement>This work was supported by the Gates Foundation [INV-019356]. </funding-statement>
                <funding-statement>
                    <italic>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</italic>
                </funding-statement>
            </funding-group>
        </article-meta>
    </front>
    <body>
        <sec sec-type="intro">
            <title>Introduction</title>
            <sec>
                <title>Setting the stage</title>
                <p>Since 2009, countries across the world have made substantial progress in identifying undiagnosed People Living with HIV (PLHIV) and initiating them on treatment, with the number of people worldwide increasing from 6 million to 29.8 million by 2022 (
                    <xref ref-type="bibr" rid="ref-30">UNAIDS, 2023</xref>). However, many of those enrolled in ART have not remained on treatment. For example, in Zimbabwe, it is estimated that 20% of all PLHIV enrolled on ART are lost to follow-up, and in Malawi this estimate is 26% (
                    <xref ref-type="bibr" rid="ref-17">MPHIA 2020-2021</xref>; 
                    <xref ref-type="bibr" rid="ref-25">ZIMPHIA, 2020</xref>). These losses threaten to undermine the tremendous gains of the HIV response, harming not just the health of PLHIV who stop treatment, but that of their sexual partners and children.</p>
                <p>Despite substantial and ever-growing evidence that PLHIV with undetectable viral loads do not infect their sexual partners, very few PLHIV know that being on ART will prevent them from transmitting the virus (
                    <xref ref-type="bibr" rid="ref-9">Bor 
                        <italic toggle="yes">et al.</italic>, 2021</xref>; 
                    <xref ref-type="bibr" rid="ref-20">Siegel &amp; Meunier, 2019</xref>). Instead, across sub-Saharan Africa, ART is still powerfully associated with HIV itself. Using antiretrovirals has become a source of stigma and shame rather than a source of control, responsibility, or respect (
                    <xref ref-type="bibr" rid="ref-8">Blake Helms 
                        <italic toggle="yes">et al.</italic>, 2017</xref>).</p>
                <p>"Undetectable = Untransmittable" (U=U) has emerged as a crucial global intervention in HIV management, originated from scientific evidence that people with HIV who maintain an undetectable viral load through adherence to Antiretroviral Therapy (ART) cannot sexually transmit the virus to others (
                    <xref ref-type="bibr" rid="ref-2">Aoko 
                        <italic toggle="yes">et al.</italic>, 2023</xref>; 
                    <xref ref-type="bibr" rid="ref-5">Bavinton 
                        <italic toggle="yes">et al.</italic>, 2018</xref>; 
                    <xref ref-type="bibr" rid="ref-6">Bavinton 
                        <italic toggle="yes">et al.</italic>, 2019</xref>; 
                    <xref ref-type="bibr" rid="ref-14">Cohen 
                        <italic toggle="yes">et al.</italic>, 2011</xref>; 
                    <xref ref-type="bibr" rid="ref-16">Loutfy 
                        <italic toggle="yes">et al.</italic>, 2013</xref>; 
                    <xref ref-type="bibr" rid="ref-19">Rodger 
                        <italic toggle="yes">et al.</italic>, 2016</xref>; 
                    <xref ref-type="bibr" rid="ref-24">Yombi &amp; Mertes, 2018</xref>). The U=U movement, founded by the Prevention Access Campaign in 2016, not only brought forth a new dimension in biomedical HIV prevention but also sought to dismantle HIV-related stigma (
                    <xref ref-type="bibr" rid="ref-1">Prevention Access Campaign, (n.d.)</xref>).</p>
                <p>Examples like San Francisco's "Getting to Zero" campaign, which incorporated U=U as a key component, witnessed a substantial reduction in new HIV diagnoses by leveraging the preventive benefits of viral suppression (
                    <xref ref-type="bibr" rid="ref-11">Buchbinder &amp; Havlir, 2019</xref>). Similarly, in Australia, the "Opposites Attract" study substantiated that amongst serodiscordant couples, where the HIV-positive partner maintained viral suppression, there were zero linked HIV transmissions (
                    <xref ref-type="bibr" rid="ref-4">Bavinton 
                        <italic toggle="yes">et al.</italic>, 2014</xref>).</p>
                <p>Nonetheless, the global understanding of the U=U concept and its policy and programmatic adoption have been imbalanced. In Africa and Asia, awareness, attitudes, and practices regarding U=U have varied starkly, influenced by factors such as socio-cultural norms, healthcare professional knowledge, and government-led HIV initiatives. A systematic review "Changing Knowledge and Attitudes Towards HIV Treatment-as-Prevention and Undetectable=Untransmittable&#x201d; illuminates a discernible gap in the awareness and acceptance of the U=U message globally, with a notably limited penetration in Sub-Saharan Africa as compared to other regions. The article underscores the imperative to enhance knowledge translation and adoption of U=U, particularly in high HIV burden settings like Zimbabwe and Malawi (
                    <xref ref-type="bibr" rid="ref-9">Bor 
                        <italic toggle="yes">et al.</italic>, 2021</xref>).</p>
                <p>Addressing the low saturation and comprehension of the U=U message in Malawi and Zimbabwe provides a foundational challenge for our methodology. Infused with key insights from prior programming such as the &#x201c;Coach Mpilo&#x201d; project in South Africa, combined with formative qualitative and quantitative data from Malawi and Zimbabwe, our program aimed to develop a marketing and brand strategy that did not merely promote the benefits of ART but aimed to change social and individual perceptions regarding HIV treatment (
                    <xref ref-type="bibr" rid="ref-15">Hlongwa 
                        <italic toggle="yes">et al.</italic>, 2022</xref>; 
                    <xref ref-type="bibr" rid="ref-22">
                        <italic toggle="yes">The Coach Mpilo Website</italic>, n.d.</xref>). One of the key insights from the Coach Mpilo program in South Africa was the recognition that the messenger can be as impactful as the message itself (
                    <xref ref-type="bibr" rid="ref-10">Bruns, 2021</xref>; 
                    <xref ref-type="bibr" rid="ref-15">Hlongwa 
                        <italic toggle="yes">et al.</italic>, 2022</xref>). Therefore, our methodology places strong emphasis on the identification and utilization of a compelling, credible messenger &#x2013; someone who is capable of connectingthe medical world and the lived experiences of individuals in Sub-Saharan Africa. This "Flip the Script" approach aims to recalibrate ART not as a stigmatizing symbol of infection but as a key that unlocks a pathway to a normalized, healthy life for PLHIV.</p>
                <p>&#x201c;Flip the Script&#x201d; was established through a unique partnership between private and public sectors, including Ipsos Mori, Fieldstone Helms, TBWA Zimbabwe, Bwanji Malawi, PSI, the Bill &amp; Melinda Gates Foundation, PEPFAR/OGAC, and Johnson &amp; Johnson. The project was initiated to change the narrative around ART and catalyze transformative impact on PLHIV&#x2019;s lives. PSI and partners acknowledged a significant opportunity for health systems to shift counseling standards, dismantle previous stigmatizing messages, and reintroduce the prospect of sex and intimacy beyond condoms for sexual partners. The initiative aimed to break the cycle of stigma and shame in PLHIV&#x2019;s lives, fostering a life full of vibrancy, including the possibility of condomless intimacy.</p>
                <p>Grounded in human-centered and co-design approaches, the project ensured host country governments played a vital leadership role, encouraging collaboration between stakeholders, influencers, and the target audience from the outset. This strategy was crucial for crafting a globally resonant brand, while allowing for necessary country-specific adaptations in line with regional and national priorities.</p>
                <p>Aiming to transcend geographical boundaries and promote south-to-south learning across the sub-continent, the &#x201c;Flip the Script&#x201d; initiative aimed to make the U=U message more routinely communicated by trusted messengers in more comprehensible and resonant ways. Expected outcomes included:</p>
                <list list-type="bullet">
                    <list-item>
                        <p>For PLHIV: Increase ART initiation and re-initiation, promote effective use of ART, and encourage viral load test seeking and result sharing.</p>
                    </list-item>
                    <list-item>
                        <p>For Health Providers (facility and community ART Champions): Ensure consistent counseling on the prevention benefits of ART and effective communication of viral suppression advantages.</p>
                    </list-item>
                </list>
                <p>These objectives are addressed through several key intermediate outcomes:</p>
                <list list-type="bullet">
                    <list-item>
                        <p>Knowledge: Ensure that PLHIV understand the benefits of viral suppression for preventing transmission.</p>
                    </list-item>
                    <list-item>
                        <p>Motivation: Foster motivation among PLHIV to adhere to treatment.</p>
                    </list-item>
                    <list-item>
                        <p>Advocacy: Encourage PLHIV to share their treatment stories.</p>
                    </list-item>
                    <list-item>
                        <p>Attitude: Enhance providers' empathy towards PLHIV.</p>
                    </list-item>
                    <list-item>
                        <p>Self-efficacy: Boost providers' confidence in communicating the benefits of viral suppression.</p>
                    </list-item>
                    <list-item>
                        <p>Skill: Equip providers and community cadres to effectively counsel on the advantages of viral suppression for preventing transmission.</p>
                    </list-item>
                </list>
                <p>Ultimately, the initiative strived to increase the percentage of PLHIV who achieve &amp; sustain viral suppression and to reduce HIV incidence. The Theory of Change for Flip the Script presented in 
                    <xref ref-type="fig" rid="f1">Figure 1</xref>.</p>
                <fig fig-type="figure" id="f1" orientation="portrait" position="float">
                    <label>Figure 1. </label>
                    <caption>
                        <title>Flip the Script Theory of Change.</title>
                    </caption>
                    <graphic orientation="portrait" position="float" xlink:href="https://gatesopenresearch-files.f1000.com/manuscripts/16565/2ff995b4-1cd4-4d21-a93a-89ad2969cff2_figure1.gif"/>
                </fig>
            </sec>
        </sec>
        <sec sec-type="methods">
            <title>Methods</title>
            <p>This program data was guided by the ethical principles of Helensiki Declaration of Human Research. The Population Services International research board delegated the authority for review to the Medical Research Council of Zimbabwe (MRCZ)  and the social sciences and humanities in Malawi, as per their agreement for ceding review. The research study, was approved by the Medical Research Council of Zimbabwe (MRCZ) in December 2020 with the reference number MRCZ/A/2772, while the National Committee on Research Ethics in the Social Sciences and Humanities in Malawi approved the research with the reference number NCST/RTT/2/6 in December 2020. We have the talent rights for all the people who participated in the adverts. Written informed consent was sought and granted for all people who participated in the mixed methods study.</p>
            <sec>
                <title>Formative research and human centered design</title>
                <p>
                    <bold>
                        <italic toggle="yes">Previous methodologies and campaigns.</italic>
                    </bold> The Flip the Script program leveraged commercial marketing tools&#x2014;including formative research, strategic marketing campaigns, and human-centered design approaches&#x2014;and ongoing stakeholder engagement to cultivate an impactful framework rooted in regional lessons learned in the HIV space. Evidence from previous studies indicates that the synergy of social marketing and key stakeholder collaboration has been pivotal in sculpting effective HIV treatment campaigns, with notable achievements in ART adherence and establishing affirmative emotional linkages among PLHIV towards their treatment (
                    <xref ref-type="bibr" rid="ref-23">Underwood 
                        <italic toggle="yes">et al.</italic>, 2014</xref>). Applications of social marketing, especially via mass media, have improved understanding and acceptance of ART, and have demonstrated the potential to simultaneously reduce the stigma attached to HIV/AIDS in countries like Malawi, by delivering behavioral programming that is both culturally and emotionally resonant (
                    <xref ref-type="bibr" rid="ref-18">Rimal &amp; Creel, 2008</xref>). This emotional resonance proves to be pivotal in crafting, designing, and implementing impactful HIV-related communication strategies, especially in the context of PLHIV in sub-Saharan Africa (
                    <xref ref-type="bibr" rid="ref-23">Underwood 
                        <italic toggle="yes">et al.</italic>, 2014</xref>).</p>
                <p>Stakeholder involvement, particularly supporting campaigns focused on HIV treatment and management, is recognized not merely as a procedural formality but as a fundamental element that guarantees the cultural relevance, community acceptance, and effectiveness of the campaign with its target audiences (
                    <xref ref-type="bibr" rid="ref-3">Babalola 
                        <italic toggle="yes">et al.</italic>, 2016</xref>).</p>
                <p>
                    <bold>
                        <italic toggle="yes">Formative research.</italic>
                    </bold> After validating the theoretical underpinnings of our methodology through an extensive literature review, we set out to conduct formative research in Malawi and Zimbabwe to fill gaps from existing literature. The project started with a research phase, investigating both the existing knowledge and emotional resonance that PLHIV and healthcare workers had regarding ART and its benefits. Ipsos MORI led the research through a two-phased approach: a qualitative phase involving in-depth interviews with PLHIV, nurses, and community influencers in Malawi and Zimbabwe; and a quantitative segmentation phase targeting a larger sample of PLHIV and healthcare workers, including nurses, counsellors, and community healthcare workers. This approach aimed to learn from lived experiences, understand current perceptions, and identify strategic insights for the campaign to effectively convey its crucial messages. The interviewers were both males and females.</p>
                <p>Key research objectives included:</p>
                <list list-type="bullet">
                    <list-item>
                        <p>What are the key needs of PLHIV &amp; healthcare workers (HCWs)?</p>
                    </list-item>
                    <list-item>
                        <p>What is the current understanding of U=U and what messages resonate?</p>
                    </list-item>
                    <list-item>
                        <p>Understanding opportunities for HCWs to enhance their counseling skills for  PLHIV regarding benefits of treatment, viral suppression and continuity of care?</p>
                    </list-item>
                    <list-item>
                        <p>How can we effectively educate PLHIV and HCWs on the benefits of treatment, viral suppression, and continuity of care to change behavior?</p>
                    </list-item>
                </list>
            </sec>
            <sec>
                <title>Qualitative research</title>
                <p>We also interviewed 24 HCWs and 24 community influencers to gain insights into the perspectives influencing PLHIV. Key insights revealed that PLHIV trusted HCWs yet perceived a lack of emotional support from them. Both clients and providers had a limited understanding of U=U, and the motivation for PLHIV to adhere often stemmed from a desire to support families and communities.</p>
                <p>From PLHIV, we learned that knowledge of treatment benefits was limited, there was a strong negative association between ART and HIV, nurses were credible but often perceived as rushed, medical terminology was confusing, secrecy was a major issue, and there were specific role model preferences for male and female PLHIV. Some key insights included:</p>
                <list list-type="bullet">
                    <list-item>
                        <p>
                            <bold>Treatment knowledge is limited:</bold> Most participants are aware of viral suppression but remain uninformed that a key benefit of ART is that with viral load suppression, a person living with HIV cannot transmit the virus, which allows for a return to pre-diagnosis sexual freedom.</p>
                    </list-item>
                    <list-item>
                        <p>
                            <bold>ART is predominantly seen as the hallmark of an HIV-positive status</bold> with participants desiring to cease medication when feeling well, perceiving it as punitive, and maintaining secrecy about their medication.</p>
                    </list-item>
                    <list-item>
                        <p>
                            <bold>Nurse-patient disconnect:</bold> Despite recognizing nurses as reliable information sources, participants often find them indifferent or rushed.</p>
                    </list-item>
                    <list-item>
                        <p>
                            <bold>Confusing medical language:</bold> Clinical terminology can alienate patients, pushing them away from engaging with their treatment.</p>
                    </list-item>
                    <list-item>
                        <p>
                            <bold>Pervasive secrecy:</bold> The widespread silence surrounding ART usage amplifies feelings of isolation and fear among patients.</p>
                    </list-item>
                    <list-item>
                        <p>
                            <bold>Role models for female PLHIV:</bold> Campaigns need to highlight independent, open-minded, and progressive female figures to inspire and validate female PLHIV.</p>
                    </list-item>
                    <list-item>
                        <p>
                            <bold>Role models for male PLHIV:</bold> Portraying respected, financially successful men with a sense of community is crucial for influencing positive perceptions among male PLHIV.</p>
                    </list-item>
                </list>
                <p>From HCWs, we found a disconnect in perceptions of HIV stigma&#x2014;in clinical settings, judgment often takes precedence over empathy, providers distrust patients, and medical terminology is used to maintain professionalism. Some of the key insights from HCW that informed the design process include:</p>
                <list list-type="bullet">
                    <list-item>
                        <p>
                            <bold>Perception gap:</bold> Nurses tend to downplay HIV stigma, potentially compromising patient privacy and adherence support.</p>
                    </list-item>
                    <list-item>
                        <p>
                            <bold>Judgement prevails:</bold> Despite caring for patients, many healthcare workers judge PLHIV, especially if they believe the virus was contracted through "sinful behaviour."</p>
                    </list-item>
                    <list-item>
                        <p>
                            <bold>Professional language barrier:</bold> Healthcare workers use medical jargon to maintain professionalism, but this can confuse and distance patients.</p>
                    </list-item>
                    <list-item>
                        <p>
                            <bold>Communication sistrust:</bold> Healthcare workers often withhold information about ART's preventive transmission capabilities due to a lack of trust in patients or confidence in their own communication skills. Tools are not systematically provided to communicate new scientific concepts, like viral suppression or ART benefit of preventing onward transmission.</p>
                    </list-item>
                </list>
                <p>In exploring attitudes of those not identified as HIV positive, we found a lack of familiarity with U=U, and supportive attitudes towards PLHIV, but a reluctance to engage in romantic or sexual relationships with them, highlighting the need for broader communication about ART's capability to prevent sexual transmission.</p>
                <p>The key insights from influencers revealed that proximity to PLHIV increases empathy, attitudes towards sex and marriage are exceptions, there's judgment based on perceived causes of HIV, treatment literacy is low, and PLHIV are seen as trusted sources of inspiration. Some of the key insights from influencers that informed the design process include:</p>
                <list list-type="bullet">
                    <list-item>
                        <p>
                            <bold>Proximity enhances empathy:</bold> Knowing someone on ART fosters support and reduces stigma, though misconceptions persist.</p>
                    </list-item>
                    <list-item>
                        <p>
                            <bold>Relationship stigma:</bold> Support for family contrasts with potential relationship abandonment and avoidance of intimate relationships with HIV-positive individuals, often due to assumed infidelity.</p>
                    </list-item>
                    <list-item>
                        <p>
                            <bold>Misplaced judgement:</bold> Like healthcare workers, influencers judge based on presumed promiscuity, impacting their empathy.</p>
                    </list-item>
                    <list-item>
                        <p>
                            <bold>Low treatment awareness:</bold> Most are unaware of ART&#x2019;s transmission prevention and harbor misconceptions about severe side effects, contributing to a mindset that HIV dominates life.</p>
                    </list-item>
                    <list-item>
                        <p>
                            <bold>Role models in positive living:</bold> PLHIV leading healthy lives, especially discordant couples, are seen as inspirations, with healthcare workers and religious leaders also deemed trustworthy sources.</p>
                    </list-item>
                </list>
            </sec>
            <sec>
                <title>Quantitative research</title>
                <p>The second component of our formative research was a quantitative survey of n=786 adult PLHIV and n=504 HCWs, including nurses, counsellors, and community healthcare workers, building on pivotal themes distilled from the preceding qualitative research. This survey was key in uncovering the distribution patterns of key beliefs and depth of knowledge across both PLHIV and HCWs, enabling the creation of a psychographic segmentation of each demographic. A post-hoc hybrid cluster methodology was employed in the segmentation analysis for both young PLHIV and HCWs, considering factors such as needs, attitudes, perceptions, behaviors, and approaches towards HIV treatment.</p>
                <p>Moreover, the survey provided crucial data from the PLHIV quantitative research which informed both channel selection&#x2014;based on reach and exposure&#x2014;and identified trusted sources of information. This PLHIV segmentation allowed PSI and partners to narrow in and prioritize a target audience for the campaign that would ultimately inform the brand architecture, while the healthcare worker segmentation illuminated prevalent misunderstandings and negative attitudes among healthcare workers, thus, shaping the development of counseling tools destined for utilization in clinical settings. This quantitative segmentation was integral to comprehend whom and how to precisely target the campaign and each embedded message. PLHIV segmentation is presented in 
                    <xref ref-type="fig" rid="f2">Figure 2</xref>.</p>
                <fig fig-type="figure" id="f2" orientation="portrait" position="float">
                    <label>Figure 2. </label>
                    <caption>
                        <title>PLHIV segment overview.</title>
                    </caption>
                    <graphic orientation="portrait" position="float" xlink:href="https://gatesopenresearch-files.f1000.com/manuscripts/16565/2ff995b4-1cd4-4d21-a93a-89ad2969cff2_figure2.gif"/>
                </fig>
                <p>The five distinct PLHIV segments identified by Ipsos MORI across both countries are differentiated by demographics, adherence levels, information sources, and psychosocial factors.</p>
                <list list-type="bullet">
                    <list-item>
                        <p>The Knowledgeable Advocates are mostly under 35, face a 39% unemployment rate, and have strong treatment adherence, but struggle with life's challenges and HIV's impact on their future.</p>
                    </list-item>
                    <list-item>
                        <p>The Resilient Nurturers, predominantly older females over 30, maintain a 95% adherence rate and seek information from healthcare workers (99%), HIV workshops (39%), and WhatsApp (35%), despite concerns about societal perceptions and the risk of disclosure.</p>
                    </list-item>
                    <list-item>
                        <p>The Unsettled Youth, mainly males over 30, boast a positive outlook with 51% never missing a dose, yet sometimes lack a comprehensive understanding of HIV concepts.</p>
                    </list-item>
                    <list-item>
                        <p>The Apathetic Navigators, mostly young males under 35, have a passive approach with only 31% adhering consistently to ART, highlighting a disconnect between awareness and action.</p>
                    </list-item>
                    <list-item>
                        <p>Lastly, the Isolated Strugglers grapple with socio-economic and psychosocial hurdles, resulting in low treatment adherence at 28%, compounded by feelings of social isolation and existential challenges.</p>
                    </list-item>
                </list>
            </sec>
            <sec>
                <title>Segmentation prioritization</title>
                <p>Utilizing a set of well-defined segment prioritization criteria, the teams analyzed the research findings to identify the most critical segment for intervention:</p>
                <list list-type="bullet">
                    <list-item>
                        <p>Sufficiency: Is the population segment large enough to warrant targeting?</p>
                    </list-item>
                    <list-item>
                        <p>Actionable: How effectively can a communications campaign address the barriers and needs of the segment and motivate them to act?</p>
                    </list-item>
                    <list-item>
                        <p>Reachable: Through which channels can we efficiently reach the target audience?</p>
                    </list-item>
                    <list-item>
                        <p>Health Need: How pronounced is the need/health risk to this segment?</p>
                    </list-item>
                </list>
                <p>Based primarily on these criteria and the guidance of the Ministries of Health, the team prioritized Segment 4, the Apathetic Navigators, as the key demographic for our intervention.</p>
                <p>This segment, comprising a significant portion of the population at 22%, is largely male and under 35 (87%), displaying a concerning ART adherence rate of 31% despite an average HIV duration of 7.6 years. Their substantial size and critical health need, paired with their actionability and reachability, make them an optimal target.</p>
                <p>The Apathetic Navigators' disconnect between HIV knowledge and treatment action, combined with prevalent misconceptions, positions them as a segment that could benefit significantly from a targeted communications campaign. Their relative indifference to societal perceptions simplifies the intervention framing and messaging.</p>
                <p>They were also deemed reachable due to their openness to HIV-related communication. Given that 62% have awareness of HIV/ARVs, strategies can leverage this to convert apathy into action.</p>
                <p>In both Zimbabwe and Malawi, Segment 4 offers challenges and opportunities for impactful interventions, from empowering and proactive health management to addressing healthcare access and misinformation. The success in these countries could inform strategies across sub-Saharan Africa, considering the region's shared PLHIV challenges.</p>
                <p>While HCWs play a critical role, the team chose not to prioritize one segment of HCWs as a separate focus segment, intending to maximize the use of scarce resources and foster synergies between all HCW segments for health impact.</p>
            </sec>
            <sec>
                <title>Intervention design</title>
                <p>
                    <bold>
                        <italic toggle="yes">Design method.</italic>
                    </bold> Over a period of two months starting in June 2021, the Ministries of Health in Malawi and Zimbabwe, alongside PSI, Fieldstone Helms, TBWA Zimbabwe, Bwanji Malawi, engaged in multiple virtual co-design workshops, led by a human-centered design expert. </p>
                <p>The I Can program uses an integrated channel strategy featuring radio, press, digital, print and outdoor as reinforcing mediums that complement interpersonal communication (IPC) as the core intervention. The I Can campaign features testimonial-style executions of people living with HIV who have achieved important romantic, family, work, or educational milestones because of being on treatment. These executions are delivered through a mix of media types and that mix should be informed by evidence about media usage in your target audiences and reflected in a well-considered media plan. Above the line (TV, billboard, radio, and digital) creative materials were developed using formative research, audience insights, and the creative expertise of Fieldstone Helms. Content, tone, visuals, and scripts were pretested iteratively with audience members to ensure resonance, comprehension, and emotional appeal. IPC materials for use by both HCW and ART Champions were both adopted from other successful programs and developed through design workshops with healthcare providers in Malawi and Zimbabwe. These tools, and the training that accompanies them, are the core of the campaign because successfully communicating about treatment as prevention requires one-on-one or small group interactions.</p>
                <p>Campaign concepts and tools were subjected to rapid field testing, led by Ipsos MORI, employing a real-world conversation approach to garner immediate and actionable feedback from the target demographic. Ipsos MORI recruited the same respondents from the qualitative and quantitative research components to ensure selection of Segment 4 demographic. This cycle of ideation, development, and field testing is reiterated multiple times, facilitating a continuous loop of feedback and refinement. The intervention design process ensured that the developed initiatives are grounded in theoretical assumptions and constantly informed and validated by real-time user responses.</p>
                <p>We also strategically integrated insights gleaned from Positive Youth Development (PYD) best practices, drawing on the success of prior projects focused on HIV-prevention in sub-Saharan Africa. A notable reference in this regard is the DREAMS initiative, a multi-country project that has significantly contributed to reducing HIV incidences among adolescent girls and young women in the region (
                    <xref ref-type="bibr" rid="ref-7">Birdthistle 
                        <italic toggle="yes">et al.</italic>, 2018</xref>; 
                    <xref ref-type="bibr" rid="ref-13">Chimbindi 
                        <italic toggle="yes">et al.</italic>, 2020</xref>). By fostering an environment that nurtures the inherent strengths and abilities of young people, our initiative aimed to emphasize youth empowerment and the notions of improving social capital to help Segment 4 take control of their health and make informed decisions regarding HIV prevention and treatment.</p>
                <p>Additionally, we drew inspiration from the Zvandiri program in Zimbabwe, which combines clinic-based HIV care with community-based support, provided by trained adolescents and young people living with HIV (
                    <xref ref-type="bibr" rid="ref-12">Busza 
                        <italic toggle="yes">et al.</italic>, 2017</xref>). This peer-led approach aligns with the PYD framework, emphasizing the role of positive relationships and support networks in fostering resilience and adherence to HIV treatment.</p>
                <p>By leveraging these proven strategies and integrating them into our intervention design methodology, we sought to create a supportive and empowering environment for young people living with HIV, encouraging adherence to treatment, reducing stigma, and ultimately contributing to better health outcomes.</p>
            </sec>
        </sec>
        <sec sec-type="results">
            <title>Results</title>
            <sec>
                <title>Key design insights</title>
                <p>The research in Malawi and Zimbabwe uncovered shared challenges among the PLHIV in Segment 4 in both countries. People in this segment experienced life-altering disruptions, with a stark loss of sexual and psychological security due to mandatory condom use, implying risks to partners. This led to strained relationships and weakened community ties. Additionally, while HCWs were trusted for information, their advice often lacked relevance and actionability. Despite hardships, a strong and healthy appearance, equated with societal participation and acceptance, was paramount.</p>
                <p>In Malawi, belonging and societal contribution were linked to visible health and strength, crucial in a rural agrarian setting. Thus, "looking good" equated to being healthy and capable. Interventions are needed to address these connotations, reshaping perceptions of strength in the context of HIV. Enhancing HCW communication was essential to align with PLHIV's aspirations.</p>
                <p>In Zimbabwe, HIV induced a sense of societal and familial disconnection, resulting in a feeling of apathy. Interventions aimed to foster hope, using success stories to demonstrate that a fulfilling life with HIV is possible were identified as having the highest potential. The introduction of relatable "Champions" in communities sought to shift PLHIV's self-perception from passive to active, addressing the detrimental impacts on treatment adherence and concerns about appearance.</p>
                <p>From these insights, four key themes informed our campaign design:</p>
                <list list-type="bullet">
                    <list-item>
                        <p>
                            <bold>Fitting in:</bold> Looking well equates to belonging, but the cycle of falling ill impacts this sense of inclusion, turning focus back to HIV.</p>
                    </list-item>
                    <list-item>
                        <p>
                            <bold>In control:</bold> Managing HIV with daily medication can feel disempowering, impacting one's sense of autonomy in life and health.</p>
                    </list-item>
                    <list-item>
                        <p>
                            <bold>Missing out:</bold> HIV can lead to missing out on life's valuable moments due to illness.</p>
                    </list-item>
                    <list-item>
                        <p>
                            <bold>Sexual freedom:</bold> HIV restricts the freedom of sexual life once enjoyed, and create anxiety or isolation, affecting overall well-being.</p>
                    </list-item>
                </list>
                <p>A unifying theme of &#x201c;strength&#x201d; emerged as a powerful motivating factor for treatment adherence across both countries, serving as a foundational anchor for our campaign and the overall brand architecture. In Malawi, strength was not merely physical but deeply embedded in societal value and worth. Strength signified one's capacity to contribute to communal life, especially in a predominantly agrarian setting. To be perceived as healthy, and thus strong, was tantamount to being a valuable member of the community, emphasizing the crucial role of appearance as a determinant of social inclusion.</p>
                <p>On the other hand, in Zimbabwe, the diminished sense of agency among PLHIV underscored a different dimension of strength. Their pervasive apathy and diminished self-worth were challenged by introducing real-life role models or "Champions", intending to reignite the internal strength, resilience, and belief in their potential. In both contexts, the campaign&#x2019;s focus on strength sought to redefine and reclaim the inherent power and capability of PLHIV, positioning them not as passive recipients but as empowered individuals with an active role in their communities and lives.</p>
                <p>The mapping apathetic navigator insights to brand architecture (
                    <xref ref-type="fig" rid="f3">Figure 3</xref>) highlights how the insights derived from our co-design process played an instrumental role in shaping our brand architecture&#x2014;a crucial guiding mechanism for the overarching strategy of the initiative, ensuring consistency, relevance, and impact across all program touchpoints or channels. This framework not only serves as the campaign&#x2019;s backbone, articulating its core identity and value proposition, but also aids in forging a resonant and meaningful connection with our target audience. The insights derived from our co-design process played an instrumental role in shaping this architecture, as they provided a nuanced understanding of the emotional and practical needs of PLHIV.</p>
                <fig fig-type="figure" id="f3" orientation="portrait" position="float">
                    <label>Figure 3. </label>
                    <caption>
                        <title>Mapping apathetic navigator insights to brand architecture.</title>
                    </caption>
                    <graphic orientation="portrait" position="float" xlink:href="https://gatesopenresearch-files.f1000.com/manuscripts/16565/2ff995b4-1cd4-4d21-a93a-89ad2969cff2_figure3.gif"/>
                </fig>
                <p>The theme of "Fitting In" reflects the deep-seated need for social acceptance and the fear of ostracization, highlighting the vital role of social acceptance with regard to personal well-being. This insight aligns with our Overall Equity, which focuses on reclaiming pre-diagnosis freedom and normalcy. The feeling of "In Control" ties directly to our Key Benefits, emphasizing ART's role in reinstating control over one's life and health, counteracting the daily reminder of HIV through medication. The "Missing Out" insight underscores the desire to fully participate in life's precious moments, a yearning addressed by ART's promise to let PLHIV live a full life without missing out. Lastly, the need for "Sexual Freedom" speaks to reclaiming a vital part of personal identity and relationships, aligning with ART's benefit of enabling pre-diagnosis sexual relationships.</p>
                <p>By weaving these insights into our Brand Architecture, we've crafted a campaign that resonates on a personal level with PLHIV, guiding them on a journey from fear and uncertainty to empowerment, control, and full participation in life.</p>
            </sec>
            <sec>
                <title>&#x201c;I Can&#x201d; campaign development and communication strategy</title>
                <p>With a clear brand architecture in place, our next phase delved into the design of the insights-driven brand campaign strategy, ensuring that every component of the approach was finely tuned to resonate with our audience. By leveraging the insights uncovered from our co-design process, we worked on communication objectives and messages that spoke directly to the hearts and minds of people living with HIV, addressing their deep-seated needs, aspirations, and challenges.</p>
                <p>This approach necessitated the establishment of a key umbrella message, serving as a guiding star for all our communication efforts. In the creation of the campaign, the central theme "seeing is believing" emerged from a common sentiment among PLHIV: skepticism about maintaining a fulfilling life on ART. This insight brought to life the concept that showing could be more impactful than merely telling. Thus, the campaign introduced the idea of featuring &#x201c;ART Champions," PLHIV who would exemplify the potential of life with ART adherence. These champions, sourced from varied backgrounds, would share their inspiring stories, not only chronicling their personal experiences but also providing vital treatment information.</p>
                <p>Research from countries like South Africa, Malawi, and Zimbabwe confirmed that PLHIV were more receptive to messages when relayed by someone who shares their journey (
                    <xref ref-type="bibr" rid="ref-7">Birdthistle 
                        <italic toggle="yes">et al.</italic>, 2018</xref>; 
                    <xref ref-type="bibr" rid="ref-12">Busza 
                        <italic toggle="yes">et al.</italic>, 2017</xref>; 
                    <xref ref-type="bibr" rid="ref-15">Hlongwa 
                        <italic toggle="yes">et al.</italic>, 2022</xref>). The authenticity of a messenger who's traversed the same challenges was unparalleled in enacting behavior change. This underscored the importance of having a diverse range of ART Champions to ensure an inclusive and broad-reaching impact, resonating with PLHIV across different backgrounds and experiences.</p>
                <p>To ensure the key insights are linked to the desired health outcomes, the communication objectives were established as follows to reinforce and support the key messages:</p>
                <list list-type="bullet">
                    <list-item>
                        <p>With ART adherence, I Can reclaim pre-HIV-diagnosis freedom</p>
                    </list-item>
                    <list-item>
                        <p>With ART adherence, I Cannot transmit HIV to my partners or children</p>
                    </list-item>
                    <list-item>
                        <p>With ART adherence, I Can reduce my viral load to the point where I cannot transmit the virus or become ill</p>
                    </list-item>
                    <list-item>
                        <p>Viral load can be measured with a test from my health provider</p>
                    </list-item>
                    <list-item>
                        <p>I trust my health provider to explain the benefits of treatment and help me adhere to ART</p>
                    </list-item>
                </list>
                <p>Once the communication objectives were established, the strategy partner Fieldstone Helms alongside creative partner TBWA Zimbabwe developed the &#x201c;I Can&#x201d; creative concept as an umbrella campaign idea that would tie together all campaign messaging into a positive reinforcing message to encourage and celebrate individual agency amongst PLHIV. This campaign slogan directly responds to the apathy and low self-esteem expressed by PLHIV respondents in Zimbabwe.</p>
            </sec>
            <sec>
                <title>Channel mix</title>
                <p>The campaign's channel mix was selected to ensure that each mode of communication served a distinct purpose, dovetailing with the overall strategy of enhancing ART adherence among PLHIV in Malawi and Zimbabwe. The selection of channels was a deliberate process, steered by in-depth analysis of media habits and preferences within the target demographics, facilitated by our creative partner TBWA. Their assessment was informed by historical data, insights into the audience's lifestyle, and measurable outcomes from previous campaigns.</p>
                <p>
                    <bold>
                        <italic toggle="yes">Interpersonal communication.</italic>
                    </bold> On the ground, the campaign's heartbeat was its "ART Champions" and healthcare workers, who were the focal point of community engagement. ART Champions, thriving on treatment themselves, offered one-on-one coaching and shared the empowering message of U=U, fostering a strong motivation for ART adherence and viral load testing.</p>
                <p>Tools like the Bead Bottles and the Viral Load Explainer were cleverly designed to bridge the communication gap between healthcare providers and PLHIV, making the concept of viral load tangible and understandable.</p>
                <p>The Treatment Journey Flipchart and related materials served as visual aids to further demystify the treatment process, anchoring group discussions and promoting literacy about the journey to undetectable viral loads.</p>
                <p>The campaign's informational print materials&#x2014;the Fact Sheet and FAQ Brochure&#x2014;targeted literacy enhancement, ensuring that PLHIV were well-informed about the implications of their diagnosis and the pathway to suppression.</p>
                <p>
                    <bold>
                        <italic toggle="yes">Mass media.</italic>
                    </bold> Radio and television were pivotal in harnessing the emotional connection with our audience, capturing the attention of men and HIV-negative individuals who play a supportive role in the treatment journey. These mediums allowed for a broad reach, instilling the campaign's branding and emotional resonance into the daily lives of the community. Billboards complemented this effort, offering a visual anchor for the campaign's identity in high-traffic areas, serving as constant reminders of the campaign's presence and message.</p>
                <p>
                    <bold>
                        <italic toggle="yes">Digital platforms.</italic>
                    </bold> By deploying targeted ads on Google and Facebook, we reached PLHIV where they were most comfortable, ensuring confidentiality and convenience. Social media's daily content, from posts to polls and webinars, aimed to engage the audience featuring ART champions and routinely updated content, while the campaign microsite provided more in-depth educational resources. This site was not just a hub for information but intended to be a connective thread for community and guidance, directing users towards additional support systems, including a dedicated call center.</p>
                <p>
                    <bold>
                        <italic toggle="yes">Tailored outcomes.</italic>
                    </bold> Each channel within our mix was chosen not only for its reach but also for its ability to establish a connection with the audience, instill brand recognition, and ultimately, influence behavior. The campaign capitalized on the strengths of each medium&#x2014;the emotive power and privacy of radio, the visual impact of billboards, or the interactive and supportive environment created by digital platforms and interpersonal communication&#x2014;to address behavioral objectives.</p>
            </sec>
            <sec>
                <title>Evaluation and assessment</title>
                <p>The campaign's deployment across mass and mid-media has achieved substantial outreach and engagement in its mission to enhance ART adherence among PLHIV in Zimbabwe and Malawi. The campaign commenced with a robust mass media launch on September 15th, 2021, marking its presence with over 175 TV and 2605 radio spots broadcasting crucial messaging across the airwaves in Malawi and Zimbabwe.</p>
                <p>Digital channels commenced on November 15th and have shown promising engagement, indicating that the campaign's messages are resonating with the audience. Accompanying campaign landing pages have been established, providing pivotal information and resources to PLHIV. While the official launch in Zimbabwe aligned with World AIDS Day, garnering significant attention, Malawi's launch was strategically deferred by two weeks to ensure clear and focused messaging.</p>
                <p>In terms of reach, the campaign's impact has been impressive. Zimbabwe has seen a remarkable radio reach of over 5 million, a TV audience of nearly 1.75 million, and substantial digital engagement with a Facebook reach of over 1.4 million, a staggering 13 million Google display impressions, and landing page visits surpassing 32,000. Malawi, not to be outdone, boasted radio numbers reaching over 9.5 million, a TV reach of nearly 7.8 million, Facebook reach of over 1.2 million, Google display impressions of over 4.4 million, and landing page visits of more than 56,000.</p>
                <p>On the interpersonal front, the ART Champions' impact has been deeply felt, engaging directly with over 4000 individuals through IPC interventions. This ground-level engagement has been pivotal, leading to 227 new individuals taking up ART, 1629 returning to treatment, and an additional 1,088 engaging in viral load testing. These numbers transcend mere statistics; they represent individual lives positively impacted by the campaign's efforts, fostering a significant stride towards HIV management and treatment adherence in the region.</p>
            </sec>
        </sec>
        <sec>
            <title>Future prospects and next steps for the project</title>
            <p>As we consider the future trajectory and scalability of the 'Flip the Script' campaign, several key areas have been identified for strategic development and refinement. Our collective experiences and observations thus far have underscored the importance of a nuanced approach in the creation and deployment of health communication interventions, particularly those targeting complex and sensitive health behaviors such as ART adherence among PLHIV.</p>
            <sec>
                <title>Champion integration within health systems</title>
                <p>Future iterations of the campaign will delve deeper into optimizing the integration of champion cadres within local health system realities. The selection and recruitment process will be fine-tuned to ensure that our champions not only possess the necessary skill set and empathy but also harmonize with the current health cadre structure. We aim to define the roles and responsibilities clearly, considering the workload and the level of effort to ensure longevity and prevent burnout. There is also a commitment to reinforcing the champions' sense of ownership and belonging within the health system framework, which is crucial for the sustainability of their impact.</p>
            </sec>
            <sec>
                <title>Communication channel optimization</title>
                <p>Multiple channels were used in the program, in line with best practices in social and behavior change. Mass and digital media were used to address emotional and social factors, and interpersonal communication was used within clinic and community settings to improve client-provider interactions and increase understanding of viral load suppression and the benefit of ART to prevent onward transmission.</p>
            </sec>
            <sec>
                <title>Strengthening MOH partnerships</title>
                <p>Recognizing that enduring health interventions are invariably tied to the support and stewardship of local Ministries of Health, future phases will aim to strengthen these partnerships. Enhancing the MOH's capacity to manage and implement these interventions will be pursued through capacity-building initiatives and continuous dialogue to ensure alignment with national health objectives and integration into existing public health frameworks.</p>
            </sec>
            <sec>
                <title>Scalability and the minimum viable intervention</title>
                <p>A key next step involves crystallizing the 'minimum viable intervention' that can be scaled up effectively. This task will require identifying the core components of the campaign that are critical to its success, which may involve a closer analysis of existing Randomized Controlled Trial (RCT) data. The insights gleaned will aid in developing an adaptable model that can be customized to different contexts while maintaining the integrity and effectiveness of the intervention.</p>
            </sec>
            <sec>
                <title>Data-driven decision-making and research</title>
                <p>Continuing to build on the evidence base is essential. Planned research efforts, including further RCTs, will provide robust data to guide future directions. The findings will be pivotal in refining our intervention strategies to ensure they are both impactful and efficient in resource utilization.</p>
            </sec>
            <sec>
                <title>Sustainability and legacy planning</title>
                <p>Lastly, a concerted effort will be made in planning for the sustainability and legacy of the campaign. This will involve laying down a clear roadmap for transition, ensuring that the systems and structures put in place can be maintained by local entities and integrated seamlessly into ongoing health promotion efforts.</p>
                <p>By adhering to these strategic focal points, the 'Flip the Script' campaign aims not only to maintain its current momentum but to expand its reach and efficacy, thereby contributing to lasting change in the health outcomes for PLHIV in Malawi, Zimbabwe, and beyond.</p>
                <p>Researchers intending to adopt this approach can replicate it but should carefully consider the study design and the campaign&#x2019; sustainability.</p>
            </sec>
        </sec>
    </body>
    <back>
        <sec sec-type="data-availability">
            <title>Data availability</title>
            <p>The programme data used in this paper is available upon reasonable request, considering ethical and security concerns. Access to the dataset is granted only for legitimate research purposes from the submitting and corresponding author as the data used in this paper has sensitive information that can be linked to some participants.</p>
        </sec>
        <ack>
            <title>Acknowledgements</title>
            <p>The authors thank Johnson and Johnson for their helpful suggestions throughout the work.</p>
        </ack>
        <ref-list>
            <ref id="ref-1">
                <mixed-citation publication-type="web">
                    <article-title>About - Prevention Access Campaign.</article-title>(n.d.). Retrieved October 7, 2023.
                    <ext-link ext-link-type="uri" xlink:href="https://preventionaccess.org/about-2/">Reference Source</ext-link>
                </mixed-citation>
            </ref>
            <ref id="ref-2">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Aoko</surname>
                            <given-names>A</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Pals</surname>
                            <given-names>S</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Ngugi</surname>
                            <given-names>T</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Retrospective longitudinal analysis of low-level viremia among HIV-1 infected adults on antiretroviral therapy in Kenya.</article-title>
                    <source>

                        <italic toggle="yes">EClinicalMedicine.</italic>
</source>
                    <year>2023</year>;<volume>63</volume>:
                    <elocation-id>102166</elocation-id>.
                    <pub-id pub-id-type="pmid">37649807</pub-id>
                    <pub-id pub-id-type="doi">10.1016/j.eclinm.2023.102166</pub-id>
                    <pub-id pub-id-type="pmcid">10462863</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-3">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Babalola</surname>
                            <given-names>S</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Van Lith</surname>
                            <given-names>LM</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Mallalieu</surname>
                            <given-names>EC</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>A framework for health communication across the HIV treatment continuum</article-title>.<year>2016</year>.</mixed-citation>
            </ref>
            <ref id="ref-4">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Bavinton</surname>
                            <given-names>BR</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Jin</surname>
                            <given-names>F</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Prestage</surname>
                            <given-names>G</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>The opposites attract study of viral load, HIV treatment and HIV transmission in serodiscordant homosexual male couples: design and methods.</article-title>
                    <source>

                        <italic toggle="yes">BMC Public Health.</italic>
</source>
                    <year>2014</year>;<volume>14</volume>(<issue>1</issue>): 917.
                    <pub-id pub-id-type="pmid">25190360</pub-id>
                    <pub-id pub-id-type="doi">10.1186/1471-2458-14-917</pub-id>
                    <pub-id pub-id-type="pmcid">4168197</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-5">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Bavinton</surname>
                            <given-names>BR</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Pinto</surname>
                            <given-names>AN</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Phanuphak</surname>
                            <given-names>N</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Viral suppression and HIV transmission in serodiscordant male couples: an international, prospective, observational, cohort study.</article-title>
                    <source>

                        <italic toggle="yes">Lancet HIV.</italic>
</source>
                    <year>2018</year>;<volume>5</volume>(<issue>8</issue>):<fpage>e438</fpage>&#x2013;<lpage>e447</lpage>.
                    <pub-id pub-id-type="pmid">30025681</pub-id>
                    <pub-id pub-id-type="doi">10.1016/S2352-3018(18)30132-2</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-6">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Bavinton</surname>
                            <given-names>BR</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Prestage</surname>
                            <given-names>GP</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Jin</surname>
                            <given-names>F</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Strategies used by gay male HIV serodiscordant couples to reduce the risk of HIV transmission from anal intercourse in three countries.</article-title>
                    <source>

                        <italic toggle="yes">J Int AIDS Soc.</italic>
</source>
                    <year>2019</year>;<volume>22</volume>(<issue>4</issue>):
                    <elocation-id>e25277</elocation-id>.
                    <pub-id pub-id-type="pmid">30983155</pub-id>
                    <pub-id pub-id-type="doi">10.1002/jia2.25277</pub-id>
                    <pub-id pub-id-type="pmcid">6462805</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-7">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Birdthistle</surname>
                            <given-names>I</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Schaffnit</surname>
                            <given-names>SB</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Kwaro</surname>
                            <given-names>D</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Evaluating the impact of the DREAMS partnership to reduce HIV incidence among adolescent girls and young women in four settings: a study protocol.</article-title>
                    <source>

                        <italic toggle="yes">BMC Public Health.</italic>
</source>
                    <year>2018</year>;<volume>18</volume>(<issue>1</issue>): 912.
                    <pub-id pub-id-type="pmid">30045711</pub-id>
                    <pub-id pub-id-type="doi">10.1186/s12889-018-5789-7</pub-id>
                    <pub-id pub-id-type="pmcid">6060450</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-8">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Blake Helms</surname>
                            <given-names>C</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Turan</surname>
                            <given-names>JM</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Atkins</surname>
                            <given-names>G</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Interpersonal mechanisms contributing to the association between HIV-related internalized stigma and medication adherence.</article-title>
                    <source>

                        <italic toggle="yes">AIDS Behav.</italic>
</source>
                    <year>2017</year>;<volume>21</volume>(<issue>1</issue>):<fpage>238</fpage>&#x2013;<lpage>247</lpage>.
                    <pub-id pub-id-type="pmid">26864692</pub-id>
                    <pub-id pub-id-type="doi">10.1007/s10461-016-1320-2</pub-id>
                    <pub-id pub-id-type="pmcid">4980279</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-9">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Bor</surname>
                            <given-names>J</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Fischer</surname>
                            <given-names>C</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Modi</surname>
                            <given-names>M</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Changing knowledge and attitudes towards HIV Treatment-as-Prevention and &#x201c;Undetectable&#x2009;=&#x2009;Untransmittable&#x201d;: a systematic review.</article-title>
                    <source>

                        <italic toggle="yes">AIDS Behav.</italic>
</source>
                    <year>2021</year>;<volume>25</volume>(<issue>12</issue>):<fpage>4209</fpage>&#x2013;<lpage>4224</lpage>.
                    <pub-id pub-id-type="pmid">34036459</pub-id>
                    <pub-id pub-id-type="doi">10.1007/s10461-021-03296-8</pub-id>
                    <pub-id pub-id-type="pmcid">8147591</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-10">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Bruns</surname>
                            <given-names>C</given-names>
                        </name>
</person-group>:
                    <article-title>Using human-centered design to develop a program to engage South African men living with HIV in care and treatment.</article-title>
                    <source>

                        <italic toggle="yes">Glob Health Sci Pract.</italic>
</source>
                    <year>2021</year>;<volume>9</volume>(<issue>Suppl 2</issue>):<fpage>S234</fpage>&#x2013;<lpage>S243</lpage>.
                    <pub-id pub-id-type="pmid">34845047</pub-id>
                    <pub-id pub-id-type="doi">10.9745/GHSP-D-21-00239</pub-id>
                    <pub-id pub-id-type="pmcid">8628503</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-11">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Buchbinder</surname>
                            <given-names>SP</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Havlir</surname>
                            <given-names>DV</given-names>
                        </name>
</person-group>:
                    <article-title>Getting to zero San Francisco: a collective impact approach.</article-title>
                    <source>

                        <italic toggle="yes">J Acquir Immune Defic Syndr.</italic>
</source>
                    <year>2019</year>;<volume>82 Suppl 3</volume>(<issue>Suppl 3</issue>):<fpage>S176</fpage>&#x2013;<lpage>S182</lpage>.
                    <pub-id pub-id-type="pmid">31764252</pub-id>
                    <pub-id pub-id-type="doi">10.1097/QAI.0000000000002200</pub-id>
                    <pub-id pub-id-type="pmcid">6880800</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-12">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Busza</surname>
                            <given-names>J</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Ferrand</surname>
                            <given-names>RA</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Simms</surname>
                            <given-names>V</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>The effect of community-based support for caregivers on the risk of virological failure in children and adolescents with HIV in Harare, Zimbabwe (ZENITH): an open-label, randomised controlled trial.</article-title>
                    <source>

                        <italic toggle="yes">Lancet Child Adolesc Health.</italic>
</source>
                    <year>2017</year>;<volume>1</volume>(<issue>3</issue>):<fpage>175</fpage>&#x2013;<lpage>183</lpage>.
                    <pub-id pub-id-type="pmid">29104904</pub-id>
                    <pub-id pub-id-type="doi">10.1016/S2352-4642(17)30051-2</pub-id>
                    <pub-id pub-id-type="pmcid">5656092</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-13">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Chimbindi</surname>
                            <given-names>N</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Birdthistle</surname>
                            <given-names>I</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Floyd</surname>
                            <given-names>S</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Directed and target focused multi-sectoral adolescent HIV prevention: insights from implementation of the &#x2018;DREAMS partnership&#x2019; in rural South Africa.</article-title>
                    <source>

                        <italic toggle="yes">J Int AIDS Soc.</italic>
</source>
                    <year>2020</year>;<volume>23 Suppl 5</volume>(<issue>Suppl 5</issue>):
                    <elocation-id>e25575</elocation-id>.
                    <pub-id pub-id-type="pmid">32869481</pub-id>
                    <pub-id pub-id-type="doi">10.1002/jia2.25575</pub-id>
                    <pub-id pub-id-type="pmcid">7459161</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-14">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Cohen</surname>
                            <given-names>MS</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Chen</surname>
                            <given-names>YQ</given-names>
                        </name>

                        <name name-style="western">
                            <surname>McCauley</surname>
                            <given-names>M</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Prevention of HIV-1 infection with early antiretroviral therapy.</article-title>
                    <source>

                        <italic toggle="yes">N Engl J Med.</italic>
</source>
                    <year>2011</year>;<volume>365</volume>(<issue>6</issue>):<fpage>493</fpage>&#x2013;<lpage>505</lpage>.
                    <pub-id pub-id-type="pmid">21767103</pub-id>
                    <pub-id pub-id-type="doi">10.1056/NEJMoa1105243</pub-id>
                    <pub-id pub-id-type="pmcid">3200068</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-15">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Hlongwa</surname>
                            <given-names>M</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Cornell</surname>
                            <given-names>M</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Malone</surname>
                            <given-names>S</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Uptake and short-term retention in HIV treatment among men in South Africa: the Coach Mpilo pilot project.</article-title>
                    <source>

                        <italic toggle="yes">Glob Health Sci Pract.</italic>
</source>
                    <year>2022</year>;<volume>10</volume>(<issue>1</issue>):
                    <elocation-id>e2100498</elocation-id>.
                    <pub-id pub-id-type="pmid">35294387</pub-id>
                    <pub-id pub-id-type="doi">10.9745/GHSP-D-21-00498</pub-id>
                    <pub-id pub-id-type="pmcid">8885359</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-16">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Loutfy</surname>
                            <given-names>MR</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Wu</surname>
                            <given-names>W</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Letchumanan</surname>
                            <given-names>M</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Systematic review of HIV transmission between heterosexual serodiscordant couples where the HIV-positive partner is fully suppressed on antiretroviral therapy.</article-title>
                    <source>

                        <italic toggle="yes">PLoS One.</italic>
</source>
                    <year>2013</year>;<volume>8</volume>(<issue>2</issue>):
                    <elocation-id>e55747</elocation-id>.
                    <pub-id pub-id-type="pmid">23418455</pub-id>
                    <pub-id pub-id-type="doi">10.1371/journal.pone.0055747</pub-id>
                    <pub-id pub-id-type="pmcid">3572113</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-17">
                <mixed-citation publication-type="web">
                    <article-title>Malawi Population-based HIV Impact Assessment 2020-2021 Malawi Population-based HIV Impact Assessment MPHIA 2020-2021</article-title>. (n.d.).
                    <ext-link ext-link-type="uri" xlink:href="https://dms.hiv.health.gov.mw/dataset/malawi-population-based-hiv-impact-assessment-2020-2021">Reference Source</ext-link>
                </mixed-citation>
            </ref>
            <ref id="ref-18">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Rimal</surname>
                            <given-names>RN</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Creel</surname>
                            <given-names>AH</given-names>
                        </name>
</person-group>:
                    <article-title>Applying social marketing principles to understand the effects of the 
                        <italic toggle="yes">Radio Diaries</italic> program in reducing HIV/AIDS stigma in Malawi.</article-title>
                    <source>

                        <italic toggle="yes">Health Mark Q.</italic>
</source>
                    <year>2008</year>;<volume>25</volume>(<issue>1&#x2013;2</issue>):<fpage>119</fpage>&#x2013;<lpage>146</lpage>.
                    <pub-id pub-id-type="pmid">18935882</pub-id>
                    <pub-id pub-id-type="doi">10.1080/07359680802126186</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-19">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Rodger</surname>
                            <given-names>AJ</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Cambiano</surname>
                            <given-names>V</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Bruun</surname>
                            <given-names>T</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Sexual activity without condoms and risk of HIV transmission in serodifferent couples when the HIV-positive partner is using suppressive antiretroviral therapy.</article-title>
                    <source>

                        <italic toggle="yes">JAMA.</italic>
</source>
                    <year>2016</year>;<volume>316</volume>(<issue>2</issue>):<fpage>171</fpage>&#x2013;<lpage>181</lpage>.
                    <pub-id pub-id-type="pmid">27404185</pub-id>
                    <pub-id pub-id-type="doi">10.1001/jama.2016.5148</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-20">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Siegel</surname>
                            <given-names>K</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Meunier</surname>
                            <given-names>&#x00c9;</given-names>
                        </name>
</person-group>:
                    <article-title>Awareness and perceived effectiveness of HIV treatment as prevention among men who have sex with men in New York City.</article-title>
                    <source>

                        <italic toggle="yes">AIDS Behav.</italic>
</source>
                    <year>2019</year>;<volume>23</volume>(<issue>7</issue>):<fpage>1974</fpage>&#x2013;<lpage>1983</lpage>.
                    <pub-id pub-id-type="pmid">30697639</pub-id>
                    <pub-id pub-id-type="doi">10.1007/s10461-019-02405-y</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-22">
                <mixed-citation publication-type="web">
                    <article-title>The Coach Mpilo Website</article-title>. (n.d.), Retrieved November 19, 2023.
                    <ext-link ext-link-type="uri" xlink:href="https://www.coachmpilo.co.za/">Reference Source</ext-link>
                </mixed-citation>
            </ref>
            <ref id="ref-30">
                <mixed-citation publication-type="web">
                    <collab>UNAIDS</collab>:
                    <article-title>Global HIV statistics [Internet]</article-title>.<year>2023</year>; [cited 2024 Apr 18].
                    <ext-link ext-link-type="uri" xlink:href="https://url.us.m.mimecastprotect.com/s/LjpACKrY6nHrDB484SMjLQK?domain=unaids.org">Reference Source</ext-link>
                </mixed-citation>
            </ref>
            <ref id="ref-23">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Underwood</surname>
                            <given-names>C</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Hendrickson</surname>
                            <given-names>Z</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Van Lith</surname>
                            <given-names>LM</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Role of community-level factors across the treatment cascade: a critical review.</article-title>
                    <source>

                        <italic toggle="yes">J Acquir Immune Defic Syndr.</italic>
</source>
                    <year>2014</year>;<volume>66 Suppl 3</volume>:<fpage>S311</fpage>&#x2013;<lpage>8</lpage>.
                    <pub-id pub-id-type="pmid">25007202</pub-id>
                    <pub-id pub-id-type="doi">10.1097/QAI.0000000000000234</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-24">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Yombi</surname>
                            <given-names>JC</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Mertes</surname>
                            <given-names>H</given-names>
                        </name>
</person-group>:
                    <article-title>Treatment as prevention for HIV infection: current data, challenges, and global perspectives.</article-title>
                    <source>

                        <italic toggle="yes">AIDS Rev.</italic>
</source>
                    <year>2018</year>;<volume>20</volume>(<issue>3</issue>):<fpage>131</fpage>&#x2013;<lpage>140</lpage>.
                    <pub-id pub-id-type="pmid">30264827</pub-id>
                    <pub-id pub-id-type="doi">10.24875/AIDSRev.M18000024</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-25">
                <mixed-citation publication-type="web">
                    <article-title>Zimbabwe Population-based HIV Impact Assessment 2020.</article-title>(n.d.).
                    <ext-link ext-link-type="uri" xlink:href="https://phia.icap.columbia.edu/">Reference Source</ext-link>
                </mixed-citation>
            </ref>
        </ref-list>
    </back>
    <sub-article article-type="reviewer-report" id="report36828">
        <front-stub>
            <article-id pub-id-type="doi">10.21956/gatesopenres.16565.r36828</article-id>
            <title-group>
                <article-title>Reviewer response for version 1</article-title>
            </title-group>
            <contrib-group>
                <contrib contrib-type="author">
                    <name>
                        <surname>Kufa</surname>
                        <given-names>Tendesayi</given-names>
                    </name>
                    <xref ref-type="aff" rid="r36828a1">1</xref>
                    <xref ref-type="aff" rid="r36828a2">2</xref>
                    <role>Referee</role>
                </contrib>
                <aff id="r36828a1">
                    <label>1</label>Centre for HIV and STIs, NICD, National Institute for Communicable Diseases, Johannesburg, Johannesburg, South Africa</aff>
                <aff id="r36828a2">
                    <label>2</label>University of the Witwatersrand, Johannesburg, Johannesburg, South Africa</aff>
            </contrib-group>
            <author-notes>
                <fn fn-type="conflict">
                    <p>
                        <bold>Competing interests: </bold>No competing interests were disclosed.</p>
                </fn>
            </author-notes>
            <pub-date pub-type="epub">
                <day>17</day>
                <month>7</month>
                <year>2024</year>
            </pub-date>
            <permissions>
                <copyright-statement>Copyright: &#x00a9; 2024 Kufa T</copyright-statement>
                <copyright-year>2024</copyright-year>
                <license xlink:href="https://creativecommons.org/licenses/by/4.0/">
                    <license-p>This is an open access peer review report distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
            </permissions>
            <related-article ext-link-type="doi" id="relatedArticleReport36828" related-article-type="peer-reviewed-article" xlink:href="10.12688/gatesopenres.15220.1"/>
            <custom-meta-group>
                <custom-meta>
                    <meta-name>recommendation</meta-name>
                    <meta-value>reject</meta-value>
                </custom-meta>
            </custom-meta-group>
        </front-stub>
        <body>
            <p>Flip the Script: Rebranding ART and enhancing the U=U message in Malawi and Zimbabwe</p>
            <p> </p>
            <p> Thank you for the opportunity to review this paper. It addresses a very important area in HIV prevention, care and treatment and describes a programme to rebrand ART and scale up the U=U messaging in Zimbabwe and Malawi. The paper is unnecessarily long and could have been better organised and presented for a better reading experience. &#x00a0;It is very text heavy and could have benefitted form tables with bullet points. The authors could also make use of appendices and supplementary information so that the main manuscript is more focussed. I found the methods and results mixed up such that it was difficult to understand what were results and what was background information. I have included more specific comments by section of the manuscript</p>
            <p> </p>
            <p> Abstract&#x00a0;</p>
            <p> &#x2022;&#x00a0;&#x00a0; &#x00a0;Introduction&#x00a0;</p>
            <p> o&#x00a0;&#x00a0; &#x00a0; why 2009? ART has been available for longer&#x00a0;</p>
            <p> o&#x00a0;&#x00a0; &#x00a0;The challenges in HIV care/ ART include sub-optimal adherence leading sub-optimal viral suppression, ongoing viral replication and inflammation which lead to ongoing HIV related complications. U=U also needs to tout the individual benefits of ART&#x00a0;</p>
            <p> &#x2022;&#x00a0;&#x00a0; &#x00a0;Methods</p>
            <p> o&#x00a0;&#x00a0; &#x00a0;The methods could have been better summarised. At the moment the methods are generic and don&#x2019;t mention key steps in the project e.g. &#x00a0;formative research (qualitative and quantitative research), the segmentation of the population enrolled, the development of interventions to target the identified segment and any planned evaluation</p>
            <p> &#x2022;&#x00a0;&#x00a0; &#x00a0;Results</p>
            <p> o&#x00a0;&#x00a0; &#x00a0;The results as well could be better summarised. eg why go back to redefine U=U? These results should focus on summarising the insights from formative research, the characteristics of selected segment and from the implementation of the rebranding etc</p>
            <p> &#x2022;&#x00a0;&#x00a0; &#x00a0;The conclusion doesn&#x2019;t speak to the work that was done. It&#x2019;s very generic and non-specific</p>
            <p> </p>
            <p> Introduction</p>
            <p> &#x2022;&#x00a0;&#x00a0; &#x00a0;Why 2009? What happened in 2009? ART has been available for longer&#x00a0;</p>
            <p> &#x2022;&#x00a0;&#x00a0; &#x00a0;Regarding loss to follow up, over what period was this loss to follow up (20- 26%) recorded</p>
            <p> &#x2022;&#x00a0;&#x00a0; &#x00a0;Besides loss to follow up, another challenge is sub-optimal viral suppression, leading to ongoing viral suppression and ongoing inflammation and complications</p>
            <p> &#x2022;&#x00a0;&#x00a0; &#x00a0;The authors wrote &#x201c;Instead, across sub-Saharan Africa, ART is still powerfully associated with HIV itself.&#x201d; I don&#x2019;t see how ART cannot not be associated with HIV. Is it even possible to try and do away with the association in the messaging?</p>
            <p> </p>
            <p> Methods&#x00a0;</p>
            <p> &#x2022;&#x00a0;&#x00a0; &#x00a0;The methods section needs to be better structured. A flow chart summarising all the methods and their timing would go a long way in giving an overview of what was done and when. Other proposed changes/ considerations are &#x00a0;</p>
            <p> o&#x00a0;&#x00a0; &#x00a0;Ethical considerations could come last. Also under this section what is meant by programme data being guided by ethical principles? The formative research, intervention design and the implementation of the rebranding, recruiting champions etc. should have all adhered to the ethical principles</p>
            <p> o&#x00a0;&#x00a0; &#x00a0;The descriptions of the formative research &#x2013; the qualitative and qualitative sections could be summarised and compared in a table. Some of the insights from both studies/ research could be included as supplementary information. The insights may fit better in the results sections. It seems that the qualitative research interviewed HCWs, influencers and PLHIV (as insights from patients are presented) but patients are not listed along with the influencers and HCWs</p>
            <p> o&#x00a0;&#x00a0; &#x00a0;Regarding the insights from the qualitative research &#x2013; what is meant by pre-diagnosis sexual freedom? With U=U prevention, care and treatment programmes need not worry about HIV transmission but responsible sexual behaviour is still needed for prevention of STIs, HPV, Hepatitis etc. infections which are sexually transmitted and cause significant morbidity/ illness for PLHIV&#x00a0;</p>
            <p> o&#x00a0;&#x00a0; &#x00a0;Regarding the insights from the qualitative research - Is this secrecy on the part of patients or providers?</p>
            <p> o&#x00a0;&#x00a0; &#x00a0;Quantitative research &#x2013; again the insights from the quantitative research likely better belongs to the results or in a supplementary document.&#x00a0;</p>
            <p> o&#x00a0;&#x00a0; &#x00a0;Quantitative research - how are these segments (Knowledgeable advocates &#x2013; apathetic navigators) related to the profiles/ segments in the following section- middle adherence &#x2013; lowest adherence? Are they different ways of looking at the same thing?&#x00a0;</p>
            <p> o&#x00a0;&#x00a0; &#x00a0;Also results of the segmentation and prioritisation best fits with results</p>
            <p> </p>
            <p> Results&#x00a0;</p>
            <p> &#x2022;&#x00a0;&#x00a0; &#x00a0;The results contain material that best fits with method or in a supplementary material eg the key design insights. The results should have contained outcomes of the formative research, intervention design itself and effect of the campaign that came out of the planning and design work. &#x00a0;Also demographics and clinical information for the HCWs, influencers and PLHIV enrolled</p>
            <p> &#x2022;&#x00a0;&#x00a0; &#x00a0;Regarding key design insights - where is condom use mandatory? I think condom use is low regardless of HIV or ART status.</p>
            <p> &#x2022;&#x00a0;&#x00a0; &#x00a0;Regarding segment 4 population - Did the quantitative research include screening for clinical or sub-clinical depression? Some of these feelings or ideas around isolation and not coping with illness maybe due to depression which is not uncommon in PLHIV. Not taking depression into account may result in designing interventions that maybe inadequate to address the issues&#x00a0;</p>
            <p> &#x2022;&#x00a0;&#x00a0; &#x00a0;The evaluation and assessment of the branded campaign were not described in the methods&#x00a0;</p>
            <p> &#x2022;&#x00a0;&#x00a0; &#x00a0;Regarding the ART champions &#x2013; who were they, where did they operate, was there a target for how many community members they needed to reach?&#x00a0;</p>
            <p> &#x2022;&#x00a0;&#x00a0; &#x00a0;Future prospects could include how to evaluate impact on stigma, ART initiations and retention in care in the country</p>
            <p>Is the rationale for developing the new method (or application) clearly explained?</p>
            <p>Yes</p>
            <p>Is the description of the method technically sound?</p>
            <p>Partly</p>
            <p>Are the conclusions about the method and its performance adequately supported by the findings presented in the article?</p>
            <p>Partly</p>
            <p>If any results are presented, are all the source data underlying the results available to ensure full reproducibility?</p>
            <p>No</p>
            <p>Are sufficient details provided to allow replication of the method development and its use by others?</p>
            <p>Partly</p>
            <p>Reviewer Expertise:</p>
            <p>HIV and STI epidemiology</p>
            <p>I confirm that I have read this submission and believe that I have an appropriate level of expertise to state that I do not consider it to be of an acceptable scientific standard, for reasons outlined above.</p>
        </body>
    </sub-article>
</article>
